文献速递生殖医学

轻度与常规卵巢刺激在IVF不同反应人群中的系统综述与Meta分析

Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod Update · 2021-01-01

该系统综述与Meta分析纳入31项平行组RCT,比较轻度(≤150 IU/日)与常规剂量卵巢刺激在poor、normal及非PCOS高反应人群中的临床结局与成本效益。结果显示,各人群活产率与累积活产率相似,但轻度刺激显著降低normal及高反应者的OHSS风险,normal反应者周期取消率升高,且轻度刺激促性腺激素用量更少、成本更低。

要点

  • 轻度与常规刺激在poor、normal及高反应者中每周期活产率及累积活产率均相似。
  • 轻度刺激显著降低normal及高反应者的OHSS风险,但normal反应者周期取消率升高。
  • 轻度刺激促性腺激素用量更少、成本更低,获卵数及胚胎数较少但优质胚胎比例相似。

核心结论

  • 轻度剂量IVF在poor、normal及高反应者中每周期及累积活产率与常规剂量IVF相似,证据质量中等。
  • 轻度剂量IVF在normal及高反应者中显著降低OHSS风险,但normal反应者周期取消率增加。

研究设计与样本

  • 系统综述与Meta分析,纳入31项平行组RCT:poor组15项、normal组14项、高反应组2项(排除PCOS)。
  • 检索Medline、Embase、Cochrane central、Pre-Medicine自1990年1月至2020年4月,无语言限制,偏倚风险按Cochrane手册评估,证据质量按GRADE分级。

主要发现

  • 获卵数及胚胎数较少,但优质胚胎比例在三种人群中相似(证据质量低)。

临床怎么用

  • 轻度剂量IVF可作为poor、normal及高反应者的可选方案,不降低每周期及累积活产率。
  • 对normal及高反应者,轻度剂量IVF可显著降低OHSS风险,但normal反应者需关注周期取消率升高。
  • 轻度剂量IVF促性腺激素用量更少、成本更低,具有经济优势。

局限性

  • 高反应组仅纳入2项RCT,样本量有限。
  • 周期取消率及获卵数等结局的证据质量低至极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mild ovarian stimulation has emerged as an alternative to conventional IVF with the advantages of being more patient-friendly and less expensive. Inadequate data on pregnancy outcomes and concerns about the cycle cancellation rate (CCR) have prevented mild, or low-dose, IVF from gaining wide acceptance. OBJECTIVE AND RATIONALE: To evaluate parallel-group randomised controlled trials (RCTs) on IVF where comparisons were made between a mild (≤150 IU daily dose) and conventional stimulation in terms of clinical outcomes and cost-effectiveness in patients described as poor, normal and non-polycystic ovary syndrome (PCOS) hyper-responders to IVF. SEARCH METHODS: Searches with no language restrictions were performed using Medline, Embase, Cochrane central, Pre-Medicine from January 1990 until April 2020, using pre-specified search terms. References of included studies were hand-searched as well as advance access articles to key journals. Only parallel-group RCTs that used ≤150 IU daily dose of gonadotrophin as mild-dose IVF (MD-IVF) and compared with a higher conventional dose (CD-IVF) were included. Studies were grouped under poor, normal or hyper-responders as described by the authors in their inclusion criteria. Women with PCOS were excluded in the hyper-responder group. The risk of bias was assessed as per Cochrane Handbook for the included studies. The quality of evidence (QoE) was assessed according to the GRADE system. PRISMA guidance was followed for review methodology. OUTCOMES: A total of 31 RCTs were included in the analysis: 15 in the poor, 14 in the normal and 2 in the hyper-responder group. Live birth rates (LBRs) per randomisation were similar following use of MD-IVF in poor (relative risk (RR) 0.91 (CI 0.68, 1.22)), normal (RR 0.88 (CI 0.69, 1.12)) and hyper-responders (RR 0.98 (CI 0.79, 1.22)) when compared to CD-IVF. QoE was moderate. Cumulative LBRs (5 RCTs, n = 2037) also were similar in all three patient types (RR 0.96 (CI 0.86 1.07) (moderate QoE). Risk of ovarian hyperstimulation syndrome was significantly less with MD-IVF than CD-IVF in both normal (RR 0.22 (CI 0.10, 0.50)) and hyper-responders (RR 0.47 (CI 0.31, 0.72)), with moderate QoE. The CCRs were comparable in poor (RR 1.33 (CI 0.96, 1.85)) and hyper-responders (RR 1.31 (CI 0.98, 1.77)) but increased with MD-IVF among normal responders (RR 2.08 (CI 1.38, 3.14)); all low to very low QoE. Although fewer oocytes were retrieved and fewer embryos created with MD-IVF, the proportion of high-grade embryos was similar in all three population types (low QoE). Compared to CD-IVF, MD-IVF was associated with less gonadotrophin use and lower cost. WIDER IMPLICATIONS: This updated review provides reassurance on using MD-IVF not only for the LBR per cycle but also for the cumulative LBR, with moderate QoE. With risks identified with 'freeze-all' strategies, it may be time to recommend mild-dose ovarian stimulation for IVF for all categories of women i.e. hyper, poor and normal responders to IVF.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Datta AK, Maheshwari A, Felix N, et al. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis. Hum Reprod Update. 2021. PMID: 33146690. doi:10.1093/humupd/dmaa035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。